Back to
VANGUARD GROUP INC
INKT4 quarters
Position history for
VANGUARD GROUP INC's holdings in MINK THERAPEUTICS INC
As of its last 13F, for Q4 2025, Vanguard Group held 67,651 shares of INKT (Mink Therapeutics), worth $754,309. It increased the position by 34,300 shares (+102.9%) from Q3 2025. Vanguard Group held INKT from Q1 2025 to Q4 2025, across 4 quarterly 13F filings.
Current Value
$754,309
Current Shares
67,651
Total Value Change
+$549,161
Total Shares Change
+43,907
Quarter-by-Quarter History
Other major holders of INKT: VANGUARD CAPITAL MANAGEMENT LLC, DnB Asset Management AS, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC